Rare Cannabinoids Slowly Revolutionizing the Pharmaceutical Industry

August 13, 2021 13:38:54

Cannabis is now legal for recreational use in 18 states and legal for medicinal use in 36 states across the country. As the plant gains more popularity, so do some of its products, the most popular ones being THC and CBD, which are cannabinoids.

Cannabinoids are compounds found in the cannabis plant. Other cannabinoids found in the cannabis plant include tetrahydrocannabivarin (“THCV”), cannabinol (“CBN”) and cannabigerol (“CBG”), among others. These rare cannabinoids don’t possess THC’s psychoactive properties and have been found to be more potent in comparison to CBD. Forecasts show that by the year 2029, the international…

Read More >>

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://ibn.fm/RYAH

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.